11:35 AM EDT, 06/20/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending moderately higher late Thursday morning, rising 0.62% to 1,426.64 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by oil and gas company Eni (E), which rose 2.4% and then biopharmaceutical firm DBV Technologies ( DBVT ) , which added 2.1%. They were followed by petroleum refiner Equinor ( EQNR ) and electronics company Philips (PHG), which were up 1.8% and 1.7%, respectively.

The decliners from continental Europe were led by biopharmaceutical companies Cellectis ( CLLS ) and Genfit ( GNFT ) , which fell 2.5% and 2%, respectively. They were followed by biopharmaceutical company Grifols ( GRFS ) and medical device maker EDAP TMS ( EDAP ) , which were down 1.5% and 1.3%, respectively.

From the UK and Ireland, the gainers were led by software firm Endava ( DAVA ) and biopharmaceutical firm Akari Therapeutics ( AKTX ) , which climbed 8.1% and 3.9%, respectively. Biopharmaceutical firm NuCana ( NCNA ) was up 2.7% and telecommunications operator Vodafone Group ( VOD ) added 2.1%.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) , which fell 2.9%, followed by biopharmaceutical company Verona Pharma ( VRNA ) and construction materials supplier CRH (CRH), which were both down 2.2%. Biopharmaceutical firm Mereo BioPharma ( MREO ) was off 1.8%.